Jiangsu Apon Medical Technology Co., Ltd. Stock

Equities

300753

CNE100003FV4

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
11.95 CNY +1.62% Intraday chart for Jiangsu Apon Medical Technology Co., Ltd. -0.33% -30.40%
Sales 2022 324M 44.72M Sales 2023 422M 58.3M Capitalization 2.16B 299M
Net income 2022 -76M -10.5M Net income 2023 8M 1.1M EV / Sales 2022 6.48 x
Net cash position 2022 181M 24.98M Net cash position 2023 126M 17.47M EV / Sales 2023 4.83 x
P/E ratio 2022
-29.8 x
P/E ratio 2023
261 x
Employees 590
Yield 2022 *
-
Yield 2023
0.38%
Free-Float 51.47%
More Fundamentals * Assessed data
Dynamic Chart
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China and Hong Kong stocks close flat ahead of May manufacturing data RE
China, Hong Kong stocks fall ahead of May manufacturing data RE
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiangsu Apon Medical Technology Co., Ltd. Approves Management Appointments CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Certain A-Shares of Jiangsu Apon Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 13-DEC-2021. CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
More news
1 day+1.62%
1 week-0.33%
1 month-1.57%
3 months+1.27%
6 months-34.81%
Current year-30.40%
More quotes
1 week
11.74
Extreme 11.74
12.19
1 month
11.74
Extreme 11.74
16.00
Current year
7.98
Extreme 7.98
17.87
1 year
7.98
Extreme 7.98
20.00
3 years
7.98
Extreme 7.98
27.36
5 years
7.98
Extreme 7.98
36.25
10 years
7.98
Extreme 7.98
36.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 16-05-14
Director of Finance/CFO 47 16-05-14
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 52 22-08-04
Director/Board Member 55 16-02-29
Chairman 56 16-05-14
More insiders
Date Price Change Volume
24-05-31 11.95 +1.62% 1,820,300
24-05-30 11.76 -1.67% 1,928,098
24-05-29 11.96 +0.93% 2,008,856
24-05-28 11.85 -1.50% 1,903,508
24-05-27 12.03 +0.33% 2,407,818

End-of-day quote Shenzhen S.E., May 30, 2024

More quotes
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 300753 Stock